EUVIMEDEUVIMED entdecken
Crossref

A Two‐Pronged Attack Against Multidrug Resistance in Hepatocellular Carcinoma Offered by Natural Triterpenoid Saponin Raddeanin A

Jing-Yi Chen, Yu-Cheng Ho, Yu-Ning Teng iD

Drug Development Research · 2026-12 · 87 (8)

DOI: 10.1002/ddr.70415 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 18.11.2026. Verfasst von Jing-Yi Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan, Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Drug Resistance, Neoplasm, Saponins. Die Arbeit nennt 38 Literaturangaben. Gefördert von: China Medical University, National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) significantly hampers effective cancer treatment, particularly in hepatocellular carcinoma (HCC). Natural compounds, such as Raddeanin A (RA), have shown promise in reversing MDR. This study investigates the efficacy and mechanisms by which RA overcomes MDR in HCC cells. The human hepatocellular carcinoma cell line HepG2 and its multidrug‐resistant variant, HepG2/VIN, were used. Cytotoxicity assays, membrane fluidity assessments, and evaluations of ATP‐binding cassette (ABC) transporter activity were conducted to elucidate the mechanisms of RA. Additionally, the production of reactive oxygen species (ROS) and the induction of apoptosis were analyzed. RA effectively reversed resistance to chemotherapeutic agents, significantly reducing their IC 50 values in HepG2/VIN cells. Mechanistically, RA enhanced membrane fluidity and downregulated P‐glycoprotein (P‐gp) expression, inhibiting its efflux function. RA also induced ROS production, leading to mitochondrial dysfunction and apoptosis. Notably, RA exhibited uncompetitive inhibition of doxorubicin efflux, indicating a novel interaction with P‐gp. RA employs a dual mechanism to combat MDR in HCC by modulating membrane fluidity and inducing apoptosis via ROS generation. These findings suggest that RA could serve as a potential therapeutic agent in overcoming MDR, warranting further investigation in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsDrug Resistance, NeoplasmSaponinsDrug Resistance, MultipleTriterpenesHumansReactive Oxygen SpeciesApoptosisHep G2 CellsDoxorubicinMembrane FluidityATP Binding Cassette Transporter, Subfamily B, Member 1

Stichwörter der Autor:innen

Raddeanin Ahepatocellular carcinomamultidrug resistance

Substanzen

SaponinsReactive Oxygen Speciesraddeanin ADoxorubicinATP Binding Cassette Transporter, Subfamily B, Member 1Triterpenes

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, College of Medical Science and Technology, I-Shou University, Kaohsiung, Taiwan, Republic of China.
  • School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan, Republic of China.
  • School of Pharmacy, China Medical University, Taichung City, Taiwan, Republic of China.

ORCID-Profile: Yu-Ning Teng

Förderung

  • China Medical University
  • National Science and Technology Council, Taiwan

Zitieren

APA

Chen, J. Y., Ho, Y. C., & Teng, Y. N. (2026). A Two‐Pronged Attack Against Multidrug Resistance in Hepatocellular Carcinoma Offered by Natural Triterpenoid Saponin Raddeanin A. Drug Development Research, 87(8). https://doi.org/10.1002/ddr.70415

Vancouver

Chen JY, Ho YC, Teng YN. A Two‐Pronged Attack Against Multidrug Resistance in Hepatocellular Carcinoma Offered by Natural Triterpenoid Saponin Raddeanin A. Drug Development Research. 2026;87(8). doi:10.1002/ddr.70415

BibTeX
@article{Chen2026,
  author = {Chen, Jing-Yi and Ho, Yu-Cheng and Teng, Yu-Ning},
  title = {A Two‐Pronged Attack Against Multidrug Resistance in Hepatocellular Carcinoma Offered by Natural Triterpenoid Saponin Raddeanin A},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {8},
  doi = {10.1002/ddr.70415}
}
Kostenlos starten →